{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:09Z","timestamp":1761559989430,"version":"3.44.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":995,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program","award":["2-U54-AI-057153","AI40065"],"award-info":[{"award-number":["2-U54-AI-057153","AI40065"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.virol.2010.09.013","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T09:35:43Z","timestamp":1287480943000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins"],"prefix":"10.1016","volume":"408","author":[{"given":"Richard B.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.virol.2010.09.013_bb0005","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.4049\/jimmunol.178.9.5465","article-title":"Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response","volume":"178","author":"Adamopoulou","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2010.09.013_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: a review of preclinical and clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"3 Suppl","key":"10.1016\/j.virol.2010.09.013_bb0020","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/01.TP.0000153290.75695.31","article-title":"T and B cell cooperation: a dance of life and death","volume":"79","author":"Bernard","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0952-7915(00)00216-8","article-title":"B lymphocyte activation by contact-mediated interactions with T lymphocytes","volume":"13","author":"Bishop","year":"2001","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.virol.2010.09.013_bb0030","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1371\/journal.ppat.0030144","article-title":"Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection","volume":"3","author":"Calvo-Calle","year":"2007","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.virol.2010.09.013_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ni727","article-title":"Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung","volume":"2","author":"Chen","year":"2001","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0040","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virol.2010.09.013_bb0045","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1172\/JCI25078","article-title":"Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein\u2013Barr virus-associated infectious mononucleosis","volume":"115","author":"Clute","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.virol.2010.09.013_bb0050","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0055","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.01280-06","article-title":"Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry","volume":"81","author":"Cornberg","year":"2007","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2010.09.013_bb0060","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.0902168","article-title":"CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections","volume":"184","author":"Cornberg","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.virol.2010.09.013_bb0065","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.virol.2010.09.013_bb0070","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0085","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.vaccine.2008.12.035","article-title":"The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays","volume":"27","author":"Duke-Cohan","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/infdis\/161.3.446","article-title":"The persistence of neutralizing antibodies after revaccination against smallpox","volume":"161","author":"el-Ad","year":"1990","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virol.2010.09.013_bb0095","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/340517","article-title":"Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination","volume":"185","author":"Ennis","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.virol.2010.09.013_bb0100","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinids\/4.5.916","article-title":"A successful eradication campaign. Global eradication of smallpox","volume":"4","author":"Fenner","year":"1982","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.virol.2010.09.013_bb0105","series-title":"Smallpox and Its Eradication","volume":"6","author":"Fenner","year":"1988"},{"issue":"14","key":"10.1016\/j.virol.2010.09.013_bb0110","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.vaccine.2007.12.059","article-title":"Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine","volume":"26","author":"Ferrier-Rembert","year":"2008","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.virol.2010.09.013_bb0115","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2010.09.013_bb0120","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.virol.2010.09.013_bb0125","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.290.11.1452-a","article-title":"Risks of smallpox vaccination","volume":"290","author":"Fulginiti","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"27\u201328","key":"10.1016\/j.virol.2010.09.013_bb0140","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","article-title":"Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies","volume":"26","author":"Golden","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/peds.55.3.342","article-title":"Smallpox vaccination reactions, prophylaxis, and therapy of complications","volume":"55","author":"Goldstein","year":"1975","journal-title":"Pediatrics"},{"issue":"16","key":"10.1016\/j.virol.2010.09.013_bb0150","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1073\/pnas.0701451104","article-title":"Smallpox subunit vaccine produced in planta confers protection in mice","volume":"104","author":"Golovkin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.virol.2010.09.013_bb0155","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.virol.2010.09.013_bb0160","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1084\/jem.180.6.2353","article-title":"Precise prediction of major histocompatibility complex class II\u2013peptide interaction based on peptide side chain scanning","volume":"180","author":"Hammer","year":"1994","journal-title":"J. Exp. Med."},{"issue":"5406","key":"10.1016\/j.virol.2010.09.013_bb0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.virol.2010.09.013_bb0170","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.virol.2010.09.013_bb0175","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"5441","key":"10.1016\/j.virol.2010.09.013_bb0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.286.5441.952","article-title":"TCR-mediated internalization of peptide\u2013MHC complexes acquired by T cells","volume":"286","author":"Huang","year":"1999","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.virol.2010.09.013_bb0195","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/jvi.66.12.7217-7224.1992","article-title":"Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope","volume":"66","author":"Isaacs","year":"1992","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/156652405774962326","article-title":"Countermeasures to the bioterrorist threat of smallpox","volume":"5","author":"Jahrling","year":"2005","journal-title":"Curr. Mol. Med."},{"year":"1798","series-title":"An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox","author":"Jenner","key":"10.1016\/j.virol.2010.09.013_bb0205"},{"issue":"11","key":"10.1016\/j.virol.2010.09.013_bb0210","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.4049\/jimmunol.175.11.7550","article-title":"Diversity in the acute CD8 T cell response to vaccinia virus in humans","volume":"175","author":"Jing","year":"2005","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.virol.2010.09.013_bb0215","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.4049\/jimmunol.178.10.6374","article-title":"Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus","volume":"178","author":"Jing","year":"2007","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.virol.2010.09.013_bb0220","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1128\/JVI.00453-08","article-title":"An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling","volume":"82","author":"Jing","year":"2008","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2010.09.013_bb0225","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jasms.2005.07.015","article-title":"Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus","volume":"16","author":"Johnson","year":"2005","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"4","key":"10.1016\/j.virol.2010.09.013_bb0230","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/QAD.0b013e32802f7d7c","article-title":"Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection","volume":"21","author":"Kan","year":"2007","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmv.527","article-title":"T-Cell epitope discovery for variola and vaccinia viruses","volume":"17","author":"Kennedy","year":"2007","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"10.1016\/j.virol.2010.09.013_bb0240","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.174.7.3967","article-title":"Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responses","volume":"174","author":"Kennedy","year":"2005","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0245","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/CVI.00109-09","article-title":"Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high throughput assay","volume":"16","author":"Kennedy","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"issue":"Suppl 4","key":"10.1016\/j.virol.2010.09.013_bb0250","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.vaccine.2009.07.103","article-title":"Smallpox vaccines for biodefense","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0255","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2009.04.004","article-title":"The immunology of smallpox vaccines","volume":"21","author":"Kennedy","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"Lane","year":"1970","journal-title":"JAMA"},{"issue":"6011","key":"10.1016\/j.virol.2010.09.013_bb0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"issue":"77","key":"10.1016\/j.virol.2010.09.013_bb0270","first-page":"82","article-title":"Specific B lymphocytes efficiently pick up, process and present antigen to T cells","author":"Lanzavecchia","year":"1985","journal-title":"Behring Inst. Mitt."},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0275","first-page":"461","article-title":"Monkeypox spreads as US public-health system plays catch-up","volume":"3","author":"Larkin","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2010.09.013_bb0280","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinform."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/518793","article-title":"Antibody responses to vaccinia membrane proteins after smallpox vaccination","volume":"196","author":"Lawrence","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0290","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","article-title":"Development of a novel vaccinia-neutralization assay based on reporter-gene expression","volume":"188","author":"Manischewitz","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2010.09.013_bb0295","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.4049\/jimmunol.174.4.2212","article-title":"Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles","volume":"174","author":"Mathew","year":"2005","journal-title":"J. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.virol.2010.09.013_bb0300","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0147-9571(03)00025-0","article-title":"Smallpox vaccination and bioterrorism with pox viruses","volume":"26","author":"Mayr","year":"2003","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2010.09.013_bb0305","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0264-410X(94)00014-E","article-title":"Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences","volume":"13","author":"Meister","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0310","article-title":"Vaccines for preventing smallpox","author":"Metzger","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0315","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.179.2.1303","article-title":"Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses","volume":"179","author":"Mitra-Kaushik","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2010.09.013_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.06.018","article-title":"In silico-accelerated identification of conserved and immunogenic variola\/vaccinia T-cell epitopes","author":"Moise","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.virol.2010.09.013_bb0325","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1086\/524747","article-title":"Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January\u2013October 2003","volume":"46","author":"Morgan","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2010.09.013_bb0330","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0335","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/fmb.09.110","article-title":"Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens","volume":"5","author":"Moutaftsi","year":"2010","journal-title":"Future Microbiol"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM196701192760301","article-title":"Complications of smallpox vaccination. I. National survey in the United States, 1963","volume":"276","author":"Neff","year":"1967","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.virol.2010.09.013_bb0345","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1096\/fasebj.5.13.1833257","article-title":"T helper cell-dependent B cell activation","volume":"5","author":"Noelle","year":"1991","journal-title":"FASEB J."},{"issue":"39","key":"10.1016\/j.virol.2010.09.013_bb0350","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0506768102","article-title":"HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation","volume":"102","author":"Oseroff","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.virol.2010.09.013_bb0355","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1016\/j.vaccine.2005.08.010","article-title":"Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy","volume":"24","author":"Otero","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0360","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.175.8.5504","article-title":"HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products","volume":"175","author":"Pasquetto","year":"2005","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0365","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.4049\/jimmunol.175.8.5504","article-title":"HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products","volume":"175","author":"Pasquetto","year":"2005","journal-title":"J. Immunol."},{"issue":"9457","key":"10.1016\/j.virol.2010.09.013_bb0370","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(05)70209-9","article-title":"Smallpox vaccines: from first to second to third generation","volume":"365","author":"Poland","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.virol.2010.09.013_bb0375","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00172063","article-title":"MHC ligands and peptide motifs: first listing","volume":"41","author":"Rammensee","year":"1995","journal-title":"Immunogenetics"},{"issue":"3\u20134","key":"10.1016\/j.virol.2010.09.013_bb0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"issue":"1\u20132","key":"10.1016\/j.virol.2010.09.013_bb0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0022-1759(02)00423-4","article-title":"Optimized determination of T cell epitope responses","volume":"274","author":"Roederer","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2010.09.013_bb0390","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2105-11-90","article-title":"Predicting MHC class I epitopes in large datasets","volume":"11","author":"Roomp","year":"2010","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"10.1016\/j.virol.2010.09.013_bb0395","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","article-title":"The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus","volume":"72","author":"Roper","year":"1998","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2010.09.013_bb0400","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/00365510500348252","article-title":"Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma-secreting T cells","volume":"65","author":"Ryan","year":"2005","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.virol.2010.09.013_bb0405","first-page":"207","article-title":"Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT","volume":"302","author":"Ryan","year":"2005","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","article-title":"Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens","volume":"371","author":"Sakhatskyy","year":"2008","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2010.09.013_bb0415","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1084\/jem.188.9.1705","article-title":"Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations","volume":"188","author":"Selin","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.virol.2010.09.013_bb0420","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2008.04.018","article-title":"Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities","volume":"28","author":"Sette","year":"2008","journal-title":"Immunity"},{"issue":"Suppl 6","key":"10.1016\/j.virol.2010.09.013_bb0425","doi-asserted-by":"crossref","first-page":"G21","DOI":"10.1016\/j.vaccine.2009.10.011","article-title":"Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens","volume":"27","author":"Sette","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2010.09.013_bb0430","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res."},{"issue":"7","key":"10.1016\/j.virol.2010.09.013_bb0435","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.molimm.2008.12.016","article-title":"In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R","volume":"46","author":"Sirven","year":"2009","journal-title":"Mol. Immunol."},{"issue":"13","key":"10.1016\/j.virol.2010.09.013_bb0440","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2010.09.013_bb0445","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/pr700780x","article-title":"Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor","volume":"7","author":"Strug","year":"2008","journal-title":"J. Proteome Res."},{"issue":"20","key":"10.1016\/j.virol.2010.09.013_bb0450","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1128\/JVI.00601-06","article-title":"Human T-cell responses to vaccinia virus envelope proteins","volume":"80","author":"Tang","year":"2006","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2010.09.013_bb0455","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20022222","article-title":"Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses","volume":"197","author":"Terajima","year":"2003","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.virol.2010.09.013_bb0460","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.humimm.2008.09.009","article-title":"Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans","volume":"69","author":"Terajima","year":"2008","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2010.09.013_bb0465","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/bib\/bbl038","article-title":"Methods and protocols for prediction of immunogenic epitopes","volume":"8","author":"Tong","year":"2007","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0470","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.virol.2010.09.013_bb0475","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/JVI.00427-06","article-title":"Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice","volume":"80","author":"Tscharke","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0480","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.182.1.193","article-title":"CD4+ Th-APC with acquired peptide\/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses","volume":"182","author":"Umeshappa","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2010.09.013_bb0485","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1084\/jem.20041058","article-title":"Heterologous T cell immunity in severe hepatitis C virus infection","volume":"201","author":"Urbani","year":"2005","journal-title":"J. Exp. Med."},{"issue":"36","key":"10.1016\/j.virol.2010.09.013_bb0490","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1016\/j.vaccine.2009.05.077","article-title":"Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques","volume":"27","author":"Walsh","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2010.09.013_bb0495","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2249.2008.03856.x","article-title":"High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30years post-vaccinia virus vaccination","volume":"155","author":"Wang","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2010.09.013_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221000601X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221000601X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:07:53Z","timestamp":1758586073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221000601X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S004268221000601X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2010.09.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2010.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}